Physicians who refer for transplant or perform transplant can quickly get up to speed on the roadmap for future Blood and Marrow Transplant Clinical Trials Network (BMT CTN) trials in the U.S. Join us on Friday, Dec. 5, 2014, from 7:00 to 11:00 a.m. for A Report from the Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014 . This CME satellite symposium precedes the 2014 American Society of Hematology (ASH) Annual Meeting.
View slides to learn which clinical trials were prioritized by the NIH-founded BMT CTN in areas including:
- AML/MDS
- Non-Hodgkin lymphoma
- Myeloma
- Post-transplant care
- 8 other research priorities
Learn from leaders in the field who will provide a succinct update of current and future research impacting the progress of hematopoietic cell transplantation. Speakers include:
- Mary Horowitz, M.D., M.S. (moderator), Medical College of Wisconsin, The Center for International Blood and Bone Marrow Transplant Research, Milwaukee, WI
- Frederick Appelbaum, M.D., Fred Hutchinson Cancer Research Center, Seattle, WA
- Stella Davies, M.B.B.S., Ph.D., Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
- Steven Devine, M.D., The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
- John Wingard, M.D., University of Florida, Gainesville, FL
During an interactive panel discussion, talk with these experts about strategies for conducting successful clinical trials in the current healthcare era.
Throughout ASH, visit our booth #3039 in the South Building to receive: recently updated 2015 HCT Clinical Guidelines, including referral timing and post-transplant care; free patient resources you can distribute; and information on easy-to-access online resources.